www.mtbeurope.co.uk/news/2008/805027.htm -
[Cached Version]
Published on: 1/1/2008
Last Visited: 8/29/2008
Medtronic Inc. (NYSE: MDT) sponsored the PREFER (Pacemaker Remote Follow-up Evaluation and Review) trial, which was presented by Bruce Wilkoff, MD, Director of Cardiac Pacing and Tachyarrhythmia Devices, Department of Cardiovascular Medicine, Cleveland Clinic, and Professor of Medicine at Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.
"In the trial we found that by following patients through the Medtronic CareLink Network every three months â€" and thus having quarterly access to device diagnostics â€" clinicians are able to more quickly identify the occurrence of clinically actionable events," said Dr. Wilkoff, principal investigator for PREFER.